Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Mar;27(3):1676-1682.
doi: 10.1038/s41380-021-01380-y. Epub 2021 Dec 1.

Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes

Affiliations
Randomized Controlled Trial

Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes

Zhi-De Deng et al. Mol Psychiatry. 2022 Mar.

Abstract

Electroconvulsive therapy (ECT) remains the gold-standard treatment for patients with depressive episodes, but the underlying mechanisms for antidepressant response and procedure-induced cognitive side effects have yet to be elucidated. Such mechanisms may be complex and involve certain ECT parameters and brain regions. Regarding parameters, the electrode placement (right unilateral or bitemporal) determines the geometric shape of the electric field (E-field), and amplitude determines the E-field magnitude in select brain regions (e.g., hippocampus). Here, we aim to determine the relationships between hippocampal E-field strength, hippocampal neuroplasticity, and antidepressant and cognitive outcomes. We used hippocampal E-fields and volumes generated from a randomized clinical trial that compared right unilateral electrode placement with different pulse amplitudes (600, 700, and 800 mA). Hippocampal E-field strength was variable but increased with each amplitude arm. We demonstrated a linear relationship between right hippocampal E-field and right hippocampal neuroplasticity. Right hippocampal neuroplasticity mediated right hippocampal E-field and antidepressant outcomes. In contrast, right hippocampal E-field was directly related to cognitive outcomes as measured by phonemic fluency. We used receiver operating characteristic curves to determine that the maximal right hippocampal E-field associated with cognitive safety was 112.5 V/m. Right hippocampal E-field strength was related to the whole-brain ratio of E-field strength per unit of stimulation current, but this whole-brain ratio was unrelated to antidepressant or cognitive outcomes. We discuss the implications of optimal hippocampal E-field dosing to maximize antidepressant outcomes and cognitive safety with individualized amplitudes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Overall study design.
After randomization to either 600, 700, or 800 mA amplitudes, subjects received antidepressant ratings, neuropsychological assessments, and imaging pre-ECT (Visit 1 or “V1”), mid-ECT (V2), and post-ECT (V3). If subjects failed to respond to their assigned amplitude at the V2 assessment (defined as <25% reduction in pre-ECT HDRS24), subjects completed the protocol with bitemporal electrode placement.
Fig. 2
Fig. 2. Hippocampal E-field variability and implications for ECT dosing.
A Right and left hippocampal E-field strengths across the three amplitude arms. B Individualized amplitudes have the potential to create accurate and precise E-field dosing.
Fig. 3
Fig. 3. E-field and right hippocampal neuroplasticity.
Right hippocampal E-field was associated with right hippocampal neuroplasticity (t46 = 2.59, p = 0.01) controlling for age, sex, pulse width and number of treatments.
Fig. 4
Fig. 4. Hippocampal neuroplasticity and clinical outcomes.
A Right hippocampal E-field was not related to antidepressant outcomes (t46 = −0.62, p = 0.54). B Right hippocampal neuroplasticity had a relationship with antidepressant outcomes (t46 = −3.12, p = 0.003). C Structural equation modeling showed that right hippocampal neuroplasticity mediated the relationship between right hippocampal E-field strength and antidepressant response. D Right hippocampal E-field was associated with change in DKEFS Letter Fluency (t44 = −2.44, p = 0.02). E Right hippocampal neuroplasticity was not related to change in DKEFS Letter Fluency (t44 = −0.68, p = 0.50). F Structural equation modeling showed that right hippocampal neuroplasticity did not mediate the direct effect of right hippocampal E-field and change in DKEFS Letter Fluency. G Receiver operator characteristic curve analysis comparing right hippocampal E-field and cognitive outcome (change in DKEFS Letter Fluency > −3) revealed an area under the curve of 0.78 (95% CI: 0.64–0.93) and maximal sensitivity and specificity of 112.5 V/m.
Fig. 5
Fig. 5. Right hippocampal E-field (Er-hippo), ratio of the induced E-field in the brain per unit of stimulation current (Ebrain/Ielectrode), antidepressant, and cognition outcomes.
A Er-hippo had a direct relationship with Ebrain/Ielectrode (t48 = 8.19, p < 0.001). B Ebrain/Ielectrode was not associated with %∆HDRS (t47 = −0.40, p = 0.69). C Ebrain/Ielectrode was not associated with ∆DKEFS Letter Fluency (t45 = −1.66, p = 0.10).

Comment in

Similar articles

Cited by

References

    1. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorder: a systematic review and meta-analysis. Lancet. 2003;361:799–808. doi: 10.1016/S0140-6736(03)12705-5. - DOI - PubMed
    1. Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 2010;68:568–77. doi: 10.1016/j.biopsych.2010.06.009. - DOI - PubMed
    1. Semkovska M, Keane D, Babalola O, McLoughlin DM. Unilateral brief-pulse electroconvulsive therapy and cognition: effects of electrode placement, stimulus dosage and time. J Psychiatr Res. 2011;45:770–80. doi: 10.1016/j.jpsychires.2010.11.001. - DOI - PubMed
    1. Gbyl K, Rostrup E, Raghava JM, Andersen C, Rosenberg R, Larsson HBW, et al. Volume of hippocampal subregions and clinical improvement following electroconvulsive therapy in patients with depression. Prog neuro-Psychopharmacol Biol Psychiatry. 2021;104:110048. doi: 10.1016/j.pnpbp.2020.110048. - DOI - PubMed
    1. Gbyl K, Stottrup MM, Mitta Raghava J, Xue Jie S, Videbech P. Hippocampal volume and memory impairment after electroconvulsive therapy in patients with depression. Acta psychiatrica Scandinavica 2021;143:238–52. - PubMed

Publication types

Substances